OXiGENE Will Provide a Webcast at the Annual Cowen & Company Healthcare Conference

WALTHAM, Mass. - OXiGENE, Inc., a leading developer of biopharmaceutical compounds to treat cancer and certain ophthalmologic diseases, has announced that Dr. Richard Chin, its President and Chief Executive Officer, will present at the Cowen & Company 27th Annual Healthcare Conference at The Boston Marriott Copley Place Hotel in Boston, MA. Dr. Chin will present on Tuesday, March 13, 2007.

A live and archived webcast of the presentation can be accessed at www.oxigene.com.

OXiGENE is an emerging pharmaceutical company developing novel small-molecule therapeutics to treat cancer and eye diseases. The Company’s major focus is the clinical advancement of drug candidates that selectively disrupt abnormal blood vessels associated with solid tumor progression and visual impairment. OXiGENE is dedicated to leveraging its intellectual property position and therapeutic development expertise to bring life saving and enhancing medicines to patients.